SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-007501
Filing Date
2022-02-23
Accepted
2022-02-23 20:00:48
Documents
1
Period of Report
2022-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4142
  Complete submission text file 0000899243-22-007501.txt   5487
Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Issuer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1/3 HIGH-TECH VILLAGE GIVAT RAM, P.O. BOX 39264 JERUSALEM L3 9139102
Business Address
Kerstein David (Reporting) CIK: 0001796388 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40869 | Film No.: 22665848